The company’s board has also allotted 9,000 Debentures aggregating up to Rs 900 crore (including an option to retain oversubscription upto Rs 500 crore) having a term of 24 months from the DDA i.e. November 22, 2018. These NCDs are proposed to be listed on Wholesale Debt Market segment of NSE.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.